Ads
related to: latest research in breast cancer- Understand Your Diagnosis
See How A Metastatic Breast
Breast Cancer Treatment Works.
- MBC Treatment Option
Visit
Patient Site
- Get MBC Treatment Info
Connect With A Rep Or Register For
Updates For A Treatment Option.
- Resources For Patients
Support For You & Care Partners
View An MBC Treatment Option.
- Understand Your Diagnosis
Search results
Results From The WOW.Com Content Network
Anixa’s vaccine is a three-shot series being tested initially in breast cancer survivors, who generally have a higher recurrence rate, and targets a particular protein involved in lactation ...
The Breast Cancer Research Foundation (BCRF) is an independent, not-for-profit organization which has raised $569.4 million to support clinical and translational research on breast cancer at medical institutions in the United States and abroad. [1] BCRF currently funds over 255 researchers in 14 countries. [2]
Scientists study the behaviour of isolated cells grown in the laboratory for insights into how cells function in the body in health and disease. Experiments using cell culture are used for developing new diagnostic tests and new treatments for diseases. This is a list of major breast cancer cell lines that are primarily used in breast cancer ...
MDA-MB-231 (M D Anderson - Metastatic Breast - 231) is a human breast cancer cell line isolated at MD Anderson Cancer Center in 1973 that is used in therapeutic research, especially in the context of triple negative breast cancer. [1] [2]
The Triple Negative Breast Cancer Foundation ("TNBC Foundation") is a nonprofit organization dedicated to raising awareness of triple negative breast cancer.The foundation supports scientists and researchers in their efforts to determine the definitive causes of triple negative breast cancer so that effective detection, diagnosis, prevention, and treatment can be pursued and achieved.
Breast Cancer Research is a bimonthly peer-reviewed medical journal covering research into breast cancer. The journal was established in 1999 and is published by BioMed Central . The editor-in-chief is Lewis Chodosh ( University of Pennsylvania ).
Ad
related to: latest research in breast cancer